Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

Jeroen Frank van der Heijden, Barbara A Hutten, Harry R Büller, Martin H Prins

DOI:10.1002/14651858.CD002001

Add feedback to this review/protocol